Sort
64,565 grants matching “drug discovery”
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
$757,176Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2023 · AI
Emory Chemistry-Biology Center in the MLSCN
$757,175Raymond J Dingledine · Emory University · U54 · FY2008 · HG
Echogenic Targeted Liposomes: Transfection/Drug Delivery
$757,167David D McPherson · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · HL
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
$757,156James E Kirby · Beth Israel Deaconess Medical Center · R01 · FY2023 · AI
Rare mutations in Cystic Fibrosis: Overcoming barriers to personalized medicine
$757,115Eric J Sorscher · Emory University · R01 · FY2020 · HL
Lead Optimization of DHODH Inhibitors for Malaria
$757,086Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2018 · AI
Development of novel anti-Neisseria gonorrhoeae therapeutic agents
$757,023Daniel Patrick Flaherty · Purdue University · R01 · FY2024 · AI
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL
$756,989Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2022 · HL
Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates
$756,970Amy Kristine Bei · Yale University · R01 · FY2022 · AI
Methamphetamine and Other Substance Use Disorder Genetics in Thailand
$756,953Joel Gelernter · Yale University · R01 · FY2024 · DA
Methamphetamine and Other Substance Use Disorder Genetics in Thailand
$756,953Joel Gelernter · Yale University · R01 · FY2025 · DA
Mechanisms of Maladaptation in Heart Failure
$756,935Howard A Rockman · Duke University · R01 · FY2020 · HL
Nonlipogenic ABCA1 inducers for ADRD
$756,926Gregory R J Thatcher · University Of Arizona · U01 · FY2022 · AG
Novel Antimalarials from Fungi
$756,922Debopam Chakrabarti · University Of Central Florida · R01 · FY2022 · AI
Pain drugs based on nicotinic receptor subtype antagonists
$756,850Kelvin W Gee · University Of California-Irvine · R01 · FY2018 · DA
CINCINNATI CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCES AND TRAINING
$756,542James E. Heubi · University Of Cincinnati · UL1 · FY2009 · RR
Molecular Drivers of Vascular Stiffness and Metabolic Dysfunction in HIV-Induced Pulmonary Arterial Hypertension
$756,459Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · HL
Mouse Models of Human Cancer Database
$756,430Carol J Bult · Jackson Laboratory · R01 · FY2021 · CA
Multiplex cell-based platform for kinase drug discovery
$756,161Peter Krutzik · Primity, Inc. · R44 · FY2015 · CA
CAREER: Using C. elegans to Understand how a Fundamental Cellular Stress Response is Integrated into a Tissue System at the Interface with the Environment and to Improve Education
$756,070Keith P Choe · University Of Florida · · FY2015 · BIO
Investigating a candidate therapeutic for Rett Syndrome
$756,028Jeannie T Lee · Massachusetts General Hospital · R01 · FY2023 · MH
Investigating a candidate therapeutic for Rett Syndrome
$756,028Jeannie T Lee · Massachusetts General Hospital · R01 · FY2021 · MH
Investigating a candidate therapeutic for Rett Syndrome
$756,028Jeannie T Lee · Massachusetts General Hospital · R01 · FY2022 · MH
Surface Chemistry Studies with Ion Beams
$756,000Nicholas Winograd · Pennsylvania State Univ University Park · · FY2009 · MPS
mTOR as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target
$755,984David C Fajgenbaum · University Of Pennsylvania · R01 · FY2018 · HL